Today’s patients can get involved at either end of the “bench to bedside” cycle, explain Christopher McCabe, Executive Director and CEO, Institute of Health Economics (Canada), and Dimitrios Athanasiou, board member of United Parent Projects Muscular Dystrophy and patient representative to EURORDIS, who will also help guide patient engagement discussions at DIA Europe 2018.
Processes to better determine a medicine’s value are discussed by Dr. Indranil Bagchi, Vice President, Value and Access, Novartis Oncology, and Dr. Thomas Szucs, Professor of Pharmaceutical Medicine and Director of the European Center of Pharmaceutical Medicine at the University of Basel, who will help lead discussions on value and access at DIA Europe 2018.
Co-author Dr. Jeffrey Sherman, Chief Medical Officer / Executive Vice President at Horizon Pharmaceuticals, and DIA’s liaison to the Clinical Trials Transformation Initiative, reviews The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials with Ron Bartek, Co-Founder and President of the Friedreich’s Ataxia Research Alliance.
Poonam A. Bordoloi, Associate Director, Strategic Medical Communications & Innovation, Celgene Corporation; and David Bowers, Medical Communications Director, PPD; overview the “One Medical Voice” theme running through DIA’s Medical and Scientific Communications Forum 2018.
Wayne Pines, President for Regulatory Services and Healthcare for APCO Worldwide, shares the history of healthcare products advertising and promotion, and previews DIA’s 2018 Advertising and Promotional Regulatory Affairs Conference.
Drs. David Parkinson (ESSA Pharmaceuticals) and Gary Kelloff (US National Cancer Institute), Global Forum Translational Medicine content stream editors, explore the world’s first genetically-engineered immune therapy, CRISPR technology, the American Association for Cancer Research Project GENIE, and the potential personalization of “you on a chip.”
Global Forum Translational Medicine content stream editors Dr. Gary Kelloff (US National Cancer Institute) and Dr. David Parkinson (ESSA Pharmaceuticals) discuss the newly-formed US FDA Oncology Center of Excellence, novel data sharing initiatives in oncology, circulating tumor DNA, and their current and anticipated impacts.
Dr. Dorothee Grimald, Director of Global Regulatory Policy for MSD International in Singapore, and Chair for Accelerating Access to Innovative Products: Improving Responses to Pandemic Diseases, discusses ways to expedite patient access to combative therapies.
Saudi Arabia has the largest population and economy in the Gulf region; the Saudi Food & Drug Administration (SFDA) has correspondingly grown into one of the region’s leading regulatory agencies. The SFDA is one of many regional regulatory agencies participating in DIA EMEA's Middle East Regulatory Conference 2017 in Kuwait City. “It’s very important for us as a regulatory authority,” explains Dr. Sami Al-Sager, SFDA Executive Director for Cosmetic Products Safety, and Acting Vice President for Drug Affairs, in this Global Forum podcast.
Information is king – but to be most useful, information must be accurately and fairly communicated, explains DIA EMEA’s 11th Annual Medical Information and Communications Conference Co-Chair Dr. Lillian Auberson (Medical Information Lead for Europe at Hoffmann-La Roche, Switzerland) in this Global Forum podcast. “It’s really about thoroughly understanding exactly why we’re being asked a question,” concurs Co-Chair Janet Davies (Director, Medical Information, EMEA, Gilead Sciences Europe, UK).